Firm Record
Barclay Luke & Pillai Specialty Pharmacy PLLC dba Meta Pharmacy Services
27 findings from 3 inspection documents published by regulators. Each row below says what its date means.
US FDA · 2019-04-30 ~ 2024-01-17
Areas cited
Published inspection documents
21 CFR sections cited in FDA inspections
Citations from 1 FDA inspection (2022-12-09) of facilities listed under this company name in FDA's inspection citation data.
| As written by FDA | Inspection | Latest inspection | |
|---|---|---|---|
| 21 CFR 211.165(a) | Testing and release for distribution | 1 | 2022-12-09 |
| 21 CFR 211.84(d)(1) | Identity Testing of Each Component | 1 | 2022-12-09 |
1 site: Barclay, Luke, & Pillai Specialty Pharmacy, PLLC (Las Vegas, NV, United States) · 1 inspection
Source: FDA Data Dashboard - Inspections Citations, as of 2026-11-08. Only inspections with at least one citation are included, and a section cited more than once in one inspection counts once. Only facilities whose name and legal form match this page's documents, and that are listed in a single country, are included.
Other companies with similar findings
Other companies with findings worded closely to this company's. Only documents of the same type are compared.
A record as of publication. Check the agency's own announcements for any later corrective action.
What is included. As collected on 2026-11-15: only documents with a detail page (3 or more findings). See the firm lookup for everything.